Peg-filgrastim after autologous peripheral blood stem cell transplantation in hematological malignancies

被引：4
|
作者：
Musto, P [1 ]
Scalzulli, PR [1 ]
Melillo, L [1 ]
Nobile, M [1 ]
Dell'Olio, M [1 ]
La Sala, A [1 ]
Mantuano, S [1 ]
Bodenizza, C [1 ]
Falcone, A [1 ]
Sanpaolo, G [1 ]
Carella, AM [1 ]
Greco, MM [1 ]
Beltrami, G [1 ]
Cascavilla, N [1 ]
机构：
[1] IRCCS Casa Solievo Sofferenza, Hematol & Stem Cell Transplantat Unit, San Giovanni Rotondo, FG, Italy
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.5200.5200
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5200
引用
收藏
页码：384B / 384B
页数：1
相关论文
共 50 条
  • [21] Autologous stem cell transplantation in hematological malignancies
    Gorin, NC
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 2004, 26 (1-2): : 3 - 30
  • [22] Autologous stem cell transplantation in hematological malignancies
    Norbert-Claude Gorin
    Springer Seminars in Immunopathology, 2004, 26 : 3 - 30
  • [23] AUTOLOGOUS BLOOD STEM-CELL TRANSPLANTATION IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
    REIFFERS, J
    LEVERGER, G
    CASTAIGNE, S
    TILLY, H
    MARIT, G
    LEPAGE, E
    HENON, P
    DOUAY, L
    TROUSSARD, X
    BONE MARROW TRANSPLANTATION, 1988, 3 : 167 - 168
  • [24] Comparative effects of pegfilgrastrim and filgrastim after autologous haematopoietic peripheral blood stem cell transplantation
    Vanstraelen, G
    Frère, P
    Ngirabacu, M
    Willems, E
    Fillet, G
    Beguin, Y
    BONE MARROW TRANSPLANTATION, 2006, 37 : S74 - S74
  • [25] Efficacy and safety of biosimilar Filgrastim (Zarzio) after autologous stem cell transplant: a prospective study with historical comparison with Lenograstim and Peg-Filgrastim
    Marchesi, F.
    Vacca, M.
    Renzi, D.
    Pandolfi, A.
    Gumenyuk, S.
    Palombi, F.
    Pisani, F.
    Romano, A.
    Spadea, A.
    Provenzano, I.
    Cantonetti, M.
    Fiorini, A.
    Ipsevich, F.
    De Rienzo, M.
    Papa, E.
    Foddai, M. L.
    Arcese, W.
    Mengarelli, A.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S286 - S287
  • [26] EFFICACY AND SAFETY OF BIOSIMILAR FILGRASTIM (ZARZIO®) AFTER AUTOLOGOUS STEM CELL TRANSPLANT: A PROSPECTIVE STUDY WITH HISTORICAL COMPARISON WITH LENOGRASTIM AND PEG-FILGRASTIM
    Marchesi, F.
    Vacca, M.
    Renzi, D.
    Pandolfi, A.
    Gumenyuk, S.
    Palombi, F.
    Pisani, F.
    Romano, A.
    Spadea, A.
    Provenzano, I.
    Cantonetti, M.
    Fiorini, A.
    Ipsevich, F.
    De Rienzo, M.
    Papa, E.
    Foddai, M. L.
    Arcese, W.
    Mengarelli, A.
    HAEMATOLOGICA, 2017, 102 : 146 - 146
  • [27] Peg-filgrastim versus filgrastim after autologous stem cell tranplantation: Case-control study in patients with multiple myeloma and review of the literature
    Musto, Pellegrino
    Scalzulli, Potito Rosario
    Terruzzi, Elisabetta
    Rossini, Fausto
    Iacopino, Pasquale
    Messina, Giuseppe
    Guariglia, Roberto
    Pietrantuono, Giuseppe
    Villani, Oreste
    D'Auria, Fiorella
    Falcone, Antonietta
    Sanpaolo, Grazia
    Valvano, Maria Rosa
    Pogliani, Enrico Maria
    Morabito, Fortunato
    LEUKEMIA RESEARCH, 2007, 31 (11) : 1487 - 1493
  • [28] AUTOLOGOUS BLOOD STEM-CELL TRANSPLANTATION IN HEMATOLOGICAL MALIGNANCIES - THE ITALIAN EXPERIENCE
    IACONE, A
    DRAGANI, A
    FIORITONI, G
    QUAGLIETTA, A
    DANTONIO, D
    MONTUORO, A
    DEROSA, L
    SCIME, R
    MAJOLINO, I
    MENICHELLA, G
    PIERELLI, L
    DELAURENZI, A
    BONE MARROW TRANSPLANTATION, 1990, 5 : 46 - 47
  • [29] PEG-Filgrastim for Autologous Peripheral CD34+STEM CELL Collection in Pediatric Oncological PATIENTS: A PHASE II STUDY
    Cesaro, Simone
    Tridello, Gloria
    Zanazzo, Andrea Giulio
    Frenos, Stefano
    Messina, Chiara
    Dallorso, Sandro
    BLOOD, 2008, 112 (11) : 806 - 806
  • [30] Peripheral blood stem cell mobilization with a single dose of PEG-filgrastim in patients with multiple myeloma previously treated with radiotherapy
    Anguita-Compagnon, Alfonso T.
    Dibarrart, Maria T.
    Paredes, Laura
    Araos, Daniel
    Vargas, Marcela
    Majlis, Alejandro
    LEUKEMIA & LYMPHOMA, 2017, 58 (11) : 2724 - 2727
12345